Richard C. Yocum

Nessuna posizione attualmente

68 anni

Health Technology

Consumer Services

Distribution Services

Provenienza dei contatti di primo grado di Richard C. Yocum

Entità	Tipo di entità	Settore Industriale
LIGAND PHARMACEUTICALS INCORPORATED 26	Public Company	Pharmaceuticals: Major	26
HALOZYME THERAPEUTICS, INC. 16	Public Company	Biotechnology	16
SOPHIRIS BIO 14	Extinct	Pharmaceuticals: Major	14
Chugai Pharma USA LLC Chugai Pharma USA LLC Medical DistributorsDistribution Services Part of Roche Holding AG, Chugai Pharma USA LLC is a company that develops safe and effective drugs. The company is based in Bedminster, NJ. 3	Subsidiary	Medical Distributors	3
ROCKWELL MEDICAL, INC. 3	Public Company	Medical Specialties	3
Gensia Sicor Pharmaceuticals, Inc. 1	Subsidiary		1

Grafico delle società connesse in secondo grado

Relazione in diverse aziende

Società connesse a Richard C. Yocum tramite i suoi contatti personali

Società	Settore	Persone collegate	Posizione principale
ABBOTT LABORATORIES	Medical Specialties	George F. Horner William R. Rohn Matthew R. Hooper	Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal
AMGEN INC.	Pharmaceuticals: Major	Richard Benton Phillips Jonathan Leff Kathryn Falberg	General Counsel Chief Tech/Sci/R&D Officer Director of Finance/CFO
BRISTOL-MYERS SQUIBB COMPANY	Pharmaceuticals: Major	William R. Rohn William A. Pettit George M. Gill Ellen McDonald Sharon Real	Corporate Officer/Principal Human Resources Officer General Counsel Sales & Marketing Corporate Officer/Principal
JOHNSON & JOHNSON	Pharmaceuticals: Major	Syed M. J. Kazmi Richard Benton Phillips Matthew R. Hooper Ellen McDonald Walter H. Bee	Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal
ELI LILLY AND COMPANY	Pharmaceuticals: Major	Joseph Turner Randall E. Woods Steven T. Thornton Douglas B. Muchmore	Corporate Officer/Principal Sales & Marketing Corporate Officer/Principal Corporate Officer/Principal
PFIZER, INC.	Pharmaceuticals: Major	Richard Benton Phillips Sharon Real	Corporate Officer/Principal Corporate Officer/Principal
Scios, Inc. Scios, Inc. Pharmaceuticals: MajorHealth Technology Scios Inc. developed, manufactured, and commercialized pharmaceuticals for conditions such as cardiovascular and inflammatory diseases. The company was founded in 1981 and was headquartered in Sunnyvale, CA.	Pharmaceuticals: Major	Randal Kirk Matthew R. Hooper Walter H. Bee	Director/Board Member General Counsel Corporate Officer/Principal
Warburg Pincus LLC Warburg Pincus LLC Investment ManagersFinance Warburg Pincus LLC (Warburg Pincus) is a private equity subsidiary of Warburg Pincus & Company US LLC founded in 1966. The firm is headquartered in New York.	Investment Managers	Jonathan Leff Noah Knauf Nishan de Silva Amit Sobti	Investment Committee Member Corporate Officer/Principal Private Equity Investor Private Equity Analyst
NEUROCRINE BIOSCIENCES, INC.	Pharmaceuticals: Major	Robert J. Little Zachary Hornby William Mccarthy	Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal
BIOGEN INC.	Pharmaceuticals: Major	Connie Matsui William R. Rohn Michael LaBarre William Mccarthy	Corporate Officer/Principal Chief Operating Officer Corporate Officer/Principal Corporate Officer/Principal
Allos Therapeutics, Inc. Allos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Allos Therapeutics, Inc. is a biopharmaceutical company committed to the development and commercialization of innovative anti-cancer therapeutics. It focuses on the development and commercialization FOLOTYN a pralatrexate injection. FOLOTYN is a folate analogue metabolic inhibitor designed to accumulate preferentially in cancer cells. It targets the inhibition of dihydrofolate reductase, or DHFR, an enzyme critical in the folate pathway, thereby interfering with DNA and RNA synthesis and triggering cancer cell death. Allos Therapeutics is also developing FOLOTYN in other hematologic malignancies and solid tumors. The company was founded on September 1, 1992 and is headquartered in Westminster, CO.	Pharmaceuticals: Major	Joseph Turner Jonathan Leff Nishan de Silva	Director/Board Member Director/Board Member Director/Board Member
INTERMUNE INC	Biotechnology	James J. L'Italien Jonathan Leff Jonathan Leff	General Counsel Chief Tech/Sci/R&D Officer Director/Board Member
ARENA PHARMACEUTICALS	Pharmaceuticals: Major	Louis J. Scotti Randall E. Woods Mark R. Brunswick	Sales & Marketing Director/Board Member General Counsel
AETERNA ZENTARIS INC.	Pharmaceuticals: Major	David Mazzo Ellen McDonald	Chief Executive Officer Corporate Officer/Principal
Metabasis Therapeutics, Inc. Metabasis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Metabasis Therapeutics, Inc. engages in discovery, development and commercialization of novel drugs for metabolic diseases using the proprietary technology and the knowledge of processes and pathways within the liver that are useful for liver-selective drug targeting and treatment of metabolic diseases. Metabasis was incorporated in April 1997 and is headquartered in La Jolla, CA.	Pharmaceuticals: Major	Charles Berkman William R. Rohn	Corporate Secretary Director/Board Member
NovaCardia, Inc. NovaCardia, Inc. Pharmaceuticals: MajorHealth Technology NovaCardia, Inc. develops drugs to treat cardiovascular diseases. The company provides treatment for the patients by developing and commercializing clinical stage drug diseases. It also develops small molecule drugs. the company was founded in November, 2001 by Eckard Weber & Howard C. Dittrich and is headquartered in San Diego, CA.	Pharmaceuticals: Major	Joseph Turner Randall E. Woods	Director/Board Member Chief Executive Officer
University of Virginia	College/University	Randal Kirk Warner R. Broaddus Annamaria T. Kausz	Graduate Degree Undergraduate Degree Doctorate Degree
Stanford University	College/University	Connie Matsui Sharon Real Douglas B. Muchmore Zachary Hornby	Masters Business Admin Undergraduate Degree Undergraduate Degree Graduate Degree
University of Washington University of Washington Other Consumer ServicesConsumer Services University of Washington functions as a College/University. The company is headquartered in Seattle, WA.	College/University	Jessica Stone Rampton Annamaria T. Kausz	Undergraduate Degree Graduate Degree
Hoffmann-La Roche, Inc. Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ.	Biotechnology	Jonathan Leff Thomas H. Silberg George M. Gill	Chief Tech/Sci/R&D Officer Chief Operating Officer Corporate Officer/Principal
SGX Pharmaceuticals, Inc. SGX Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology SGX Pharmaceuticals, Inc. researches and develops drugs and other pharmaceutical products. The company was incorporated in June 20, 1999 and is headquartered in San Diego, CA.	Pharmaceuticals: Major	Richard Benton Phillips Joseph Turner	Corporate Officer/Principal Director/Board Member
XENON PHARMACEUTICALS INC.	Pharmaceuticals: Major	Frank Holler Shafique Fidai	Founder Corporate Officer/Principal
Roche Palo Alto LLC Roche Palo Alto LLC Pharmaceuticals: MajorHealth Technology Roche Palo Alto LLC discovers and develops medicines. Its medicines are used for the treatment of central nervous system, inflammation, metabolism, oncology, and virology diseases. The company was founded in 1961 and is headquartered in Palo Alto, CA.	Pharmaceuticals: Major	Jonathan Leff Robert Stein	Corporate Officer/Principal President
ReSearch Pharmaceutical Services LLC ReSearch Pharmaceutical Services LLC Miscellaneous Commercial ServicesCommercial Services ReSearch Pharmaceutical Services LLC provides clinical research services to the bio-pharmaceutical industry. Its services include analytical and product development, clinical operations, data services, medical and regulatory affairs, quality and training services. The company was founded by Daniel M. Perlman in 1998 and is headquartered in Fort Washington, PA.	Miscellaneous Commercial Services	Jonathan Leff Amit Sobti	Director/Board Member Director/Board Member
University of California, Los Angeles	College/University	Kathryn Falberg Sharon Real Ajay Gupta	Undergraduate Degree Doctorate Degree Corporate Officer/Principal
Lyon & Lyon, Inc. Lyon & Lyon, Inc. Miscellaneous Commercial ServicesCommercial Services Lyon & Lyon, Inc. engages in the provision of legal services. The company was founded on September 4, 1979 and is headquartered in San Diego, CA.	Miscellaneous Commercial Services	Charles Berkman William Larry Respess	Corporate Officer/Principal Corporate Officer/Principal
Talon Therapeutics, Inc. Talon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Talon Therapeutics, Inc. is a biopharmaceutical company, which is engaged in the developing and commercializing new and differentiated cancer therapies. The firm is developing the Marqibo for the treatment of acute lymphoblastic leukemia and other blood cancers including lymphoma. Its Menadione topical lotion is a compound which is developed for the prevention and treatment of skin toxicity associated with epidermal growth factor receptor inhibitors. The company was founded by Mark J. Ahn in 2002 and is headquartered in San Mateo, CA.	Pharmaceuticals: Major	Jonathan Leff Nishan de Silva	Director/Board Member Director/Board Member
San Diego State University	College/University	Syed M. J. Kazmi George M. Stuart	Masters Business Admin Undergraduate Degree
Massachusetts Institute of Technology	College/University	William Larry Respess Igor Bilinsky	Doctorate Degree Doctorate Degree
University of Arizona	College/University	Noah Knauf Michael LaBarre	Undergraduate Degree Doctorate Degree
University of California, Irvine	College/University	Richard Benton Phillips Patrick Walsh	Undergraduate Degree Corporate Officer/Principal
The University of Colorado	College/University	Jonathan Leff Joseph Turner	Corporate Officer/Principal Graduate Degree
University of Iowa	College/University	Michael Rocca David C. Furlano	Undergraduate Degree Doctorate Degree
Georgetown University	College/University	Carl C. Peck Annamaria T. Kausz	Corporate Officer/Principal Undergraduate Degree
Alita Pharmaceuticals, Inc. Alita Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alita Pharmaceuticals, Inc. develops, manufactures and distributes urologic and female healthcare products. It offers product testing, research and development services. The company was founded by Carole S. Ben-Maimon and Warburg Pincus in September 2006 and is headquartered in Radnor, PA.	Pharmaceuticals: Major	Jonathan Leff Nishan de Silva	Director/Board Member Director/Board Member
Hoechst Marion Roussel, Inc.		Gerry Proehl David Mazzo	Sales & Marketing Director/Board Member
PFENEX INC.	Biotechnology	Charles Berkman William R. Rohn	Director/Board Member Chairman
IGNYTA INC	Biotechnology	Alexander Casdin Igor Bilinsky Zachary Hornby William Mccarthy	Director/Board Member Corporate Officer/Principal Director of Finance/CFO Corporate Officer/Principal
Perelman School of Medicine	College/University	Jonathan Leff George M. Gill Nishan de Silva	Doctorate Degree Doctorate Degree Doctorate Degree
Stanford Graduate School of Business	College/University	Jonathan Leff Noah Knauf	Masters Business Admin Masters Business Admin
Radionetics Oncology, Inc. Radionetics Oncology, Inc. Pharmaceuticals: MajorHealth Technology Radionetics Oncology, Inc. is a clinical stage radiopharmaceutical company based in Menlo Park, CA. Radionetics Oncology, Inc. focuses on the discovery and development of novel radiotherapeutics for the treatment of various oncology indications. Radionetics Oncology spun out of Crinetics Pharmaceuticals and is supported by Frazier Life Sciences, 5AM Ventures, DCVC Bio, Crinetics Pharmaceuticals, and GordonMD Investments. The company is advancing a pipeline of small molecule radioligands that target G-protein coupled receptors to treat a wide range of cancers, including adrenocortical carcinoma, breast cancer, and lung cancer. The company's platform technology uses nonpeptide, small molecule targeting to deliver therapeutic radioisotopes selectively to tumors expressing peptide receptors. The company's pipeline consists of multiple lead drug candidates, and they are conducting additional drug discovery efforts in collaboration with Crinetics Pharmaceuticals. The market for radiopharmaceuticals is expected to rise to $12.6 billion by 2027. The company was founded by Scott R. Struthers, and Paul A. Grayson has been the CEO since 2024.	Pharmaceuticals: Major	Nishan de Silva Zachary Hornby	Chief Executive Officer Director/Board Member
OMNIAB, INC.	Miscellaneous Commercial Services	Charles Berkman Eric Vajda	General Counsel Chief Tech/Sci/R&D Officer

Statistiche

Distribuzione geografica

Stati Uniti	47
Canada	4
Irlanda	2

Settori

Health Technology	30
Consumer Services	13
Commercial Services	6
Finance	3
Retail Trade	2

Posizioni

Director/Board Member	257
Corporate Officer/Principal	153
Independent Dir/Board Member	72
Undergraduate Degree	51
President	48

Contatti più connessi

Insiders
Jonathan Leff	45
Noah Knauf	35
Robert Stein	34
Kathryn Falberg	30
Frank Holler	29
David Mazzo	23
Patrick Walsh	22
Joseph Turner	22
Randal Kirk	20
Gerry Proehl	19
Nishan de Silva	18
Alexander Casdin	17
William R. Rohn	17
Zachary Hornby	15
Jonathan Leff	14

Vedi tutte le relazioni